Literature DB >> 23824629

Cholangiocarcinoma: another masquerader in the making?

Karthik Gnanapandithan1, Satya Allaparthi, Thomas Ukena, Curuchi Anand.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 23824629     DOI： 10.1007/s12029-013-9518-2

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  21 in total

1.  New staging system and a registry for perihilar cholangiocarcinoma.

Authors:  Michelle L Deoliveira; Richard D Schulick; Yuji Nimura; Charles Rosen; Gregory Gores; Peter Neuhaus; Pierre-Alain Clavien
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

Review 2.  Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM).

Authors:  M Mandalà; A Falanga; A Piccioli; P Prandoni; E M Pogliani; R Labianca; S Barni
Journal:  Crit Rev Oncol Hematol       Date:  2006-07-11       Impact factor: 6.312

3.  Primary liver cancer: pattern of metastasis.

Authors:  Y T Lee; D A Geer
Journal:  J Surg Oncol       Date:  1987-09       Impact factor: 3.454

4.  Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period.

Authors:  Steven R Deitcher; Craig M Kessler; Geno Merli; James R Rigas; Roger M Lyons; Jawed Fareed
Journal:  Clin Appl Thromb Hemost       Date:  2006-10       Impact factor: 2.389

Review 5.  Tissue factor, thrombin, and cancer.

Authors:  Frederick R Rickles; Steven Patierno; Patricia M Fernandez
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

6.  Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.

Authors:  Jordi Rimola; Alejandro Forner; Maria Reig; Ramon Vilana; Carlos Rodríguez de Lope; Carmen Ayuso; Jordi Bruix
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

7.  Distant skeletal muscle metastasis from intrahepatic cholangiocarcinoma presenting as Budd-Chiari syndrome.

Authors:  Oh-Sung Kwon; Dae-Won Jun; Sang-Heum Kim; Mee-Yeon Chung; Nam-In Kim; Moon-Hee Song; Han-Hyo Lee; Seung-Hwan Kim; Yoon-Ju Jo; Young-Sook Park; Jong-Eun Joo
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

8.  Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.

Authors:  William R Jarnagin; Leyo Ruo; Sarah A Little; David Klimstra; Michael D'Angelica; Ronald P DeMatteo; Raquel Wagman; Leslie H Blumgart; Yuman Fong
Journal:  Cancer       Date:  2003-10-15       Impact factor: 6.860

Review 9.  Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action.

Authors:  Alok A Khorana; Michael B Streiff; Dominique Farge; Mario Mandala; Philippe Debourdeau; Francis Cajfinger; Michel Marty; Anna Falanga; Gary H Lyman
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544

10.  Middle bile duct cancer with portal vein tumor thrombus.

Authors:  Mitsugi Shimoda; Yukihiro Iso; Shigeki Tomita; Takahiro Fujimori; Koji Murakami; Tokihiko Sawada; Keiichi Kubota
Journal:  World J Surg Oncol       Date:  2008-05-10       Impact factor: 2.754
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.